Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Mitotane

Ovarian macrocyst, adnexal torsion and haemorrhagic cyst rupture: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Salenave S, et al. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease. European Journal of Endocrinology 172: 141-9, No. 2, Feb 2015 - FranceCrossRefPubMed Salenave S, et al. Ovarian macrocysts and gonadotrope-ovarian axis disruption in premenopausal women receiving mitotane for adrenocortical carcinoma or Cushing's disease. European Journal of Endocrinology 172: 141-9, No. 2, Feb 2015 - FranceCrossRefPubMed
Metadaten
Titel
Mitotane
Ovarian macrocyst, adnexal torsion and haemorrhagic cyst rupture: 3 case reports
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-0006-2

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Risperidone

Case report

Siagoside

Case report

Azathioprine